Sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309) Drug Interactions
Currently displaying a list of 326 drugs known to interact with sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309).
- 1 major drug interaction
- 322 moderate drug interactions
- 3 minor drug interactions
Medications known to interact with sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
Note: Showing generic names only.
A
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- adalimumab
- adenovirus vaccine
- afamitresgene autoleucel
- aldesleukin
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- altretamine
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- anti-thymocyte globulin (rabbit)
- asciminib
- asparaginase escherichia coli
- atezolizumab
- atidarsagene autotemcel
- avapritinib
- axicabtagene ciloleucel
- azacitidine
- azathioprine
B
- bamlanivimab
- baricitinib
- basiliximab
- bcg vaccine
- bebtelovimab
- belantamab mafodotin
- belatacept
- belimumab
- belinostat
- bendamustine
- betamethasone
- bexarotene
- bimekizumab
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- brigatinib
- brodalumab
- budesonide
- busulfan
C
- cabazitaxel
- canakinumab
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chlorambucil
- chloramphenicol
- cholera vaccine
- cholera vaccine, live
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- clozapine
- cobimetinib
- copanlisib
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- crizotinib
- cyclophosphamide
- cyclosporine
- cytarabine
D
- dacarbazine
- daclizumab
- dactinomycin
- daratumumab
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- deflazacort
- dengue vaccine
- denileukin diftitox
- deucravacitinib
- dexamethasone
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- docetaxel
- doxorubicin
- doxorubicin liposomal
- durvalumab
- duvelisib
E
- efalizumab
- efgartigimod alfa
- eflornithine
- elivaldogene autotemcel
- elotuzumab
- elranatamab
- enfortumab vedotin
- epcoritamab
- epirubicin
- eribulin
- etanercept
- etoposide
- etrasimod
- everolimus
- exagamglogene autotemcel
F
- fam-trastuzumab deruxtecan
- fexinidazole
- fingolimod
- floxuridine
- fludarabine
- fludrocortisone
- fluorouracil
- fruquintinib
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- human papillomavirus vaccine
- hyaluronan
- hydrocortisone
- hydroxyurea
I
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- inotuzumab ozogamicin
- interferon gamma-1b
- iobenguane I 131
- iodine i 131 tositumomab
- irinotecan
- irinotecan liposomal
- isatuximab
- ixabepilone
- ixazomib
- ixekizumab
J
L
- leflunomide
- lenalidomide
- leniolisib
- levamisole
- lifileucel
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- lovotibeglogene autotemcel
- lurbinectedin
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- lyme disease vaccine
- lymphocyte immune globulin, anti-thy (equine)
M
- measles virus vaccine
- mechlorethamine
- melphalan
- melphalan flufenamide
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mercaptopurine
- methotrexate
- methylprednisolone
- midostaurin
- mirikizumab
- mitomycin
- mitoxantrone
- mixed respiratory vaccine
- mogamulizumab
- momelotinib
- monomethyl fumarate
- mumps virus vaccine
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
N
O
- obinutuzumab
- ocrelizumab
- ofatumumab
- olaparib
- olaratumab
- omacetaxine
- osimertinib
- oxaliplatin
- ozanimod
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegaspargase
- pegvaliase
- pemetrexed
- pemivibart
- pentostatin
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- plicamycin
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- pomalidomide
- ponatinib
- ponesimod
- pralatrexate
- prednisolone
- prednisone
- procarbazine
Q
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ribociclib
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- romidepsin
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- rucaparib
- ruxolitinib
S
- sarilumab
- satralizumab
- selinexor
- siltuximab
- siponimod
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- smallpox and mpox vaccine
- smallpox vaccine
- sotrovimab
- spesolimab
- staphage lysate (spl)
- streptozocin
T
- tacrolimus
- tafasitamab
- talazoparib
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- temozolomide
- temsirolimus
- teniposide
- teplizumab
- teriflunomide
- tetanus toxoid
- thalidomide
- thioguanine
- thiotepa
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tisagenlecleucel
- tisotumab vedotin
- tocilizumab
- tofacitinib
- topotecan
- tositumomab
- trabectedin
- trastuzumab
- triamcinolone
- triamcinolone ophthalmic
- trimetrexate
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
- vamorolone
- varicella virus vaccine
- vedolizumab
- venetoclax
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
Y
Z
Report options
QR code containing a link to this page
More about sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.